Small Cap Value Report (Thu 5 Nov 2020) - QE, Furlough. ZOE, SDRY, D4T4, JOUL, WRKS, PCIP, BWNG, DFS, ZTF, HEAD, WIN
Good morning, it's Paul & Jack here with the SCVR for Thursday.
** Breaking News ** The Chancellor, Riski Sunak, has just announced in Parliament that the furlough scheme (recently extended from end Oct to end Nov, will now be extended to 31 March 2021. I haven't seen the small print yet, but will look out for that. Support for the self-employed has also been extended. The most important aspect of this, is that it should prevent some of the mass redundancies expected in sectors such as retailing, hospitality, travel, etc., and the knock-on impact that would have on the economy as a whole.
Although it does raise the question as to whether this means the Govt might be considering extending the lockdown of some sectors well into 2021 perhaps? At least this gives employers a chance to plan ahead with a bit of clarity. Begbies Traynor (LON:BEG) will be disappoint! Their tsunami or was it an avalanche or a hailstorm, I forget, of job losses & business failures has been pushed back by a few more months. I cannot see why the Govt would pull back on its support packages for businesses & staff. They're in too deep, hence continuing support seems logical. Especially when you can shake the magic money tree (QE) to finance it all - see below.
US Election - Markets generally have been quite settled, considering it's been election time in the USA. We're not sure yet, but it looks as if Joe Biden is highly likely to be the new President. Then of course how Congress looks will determine what he can actually do. I studied US politics as part of my degree, but have forgotten most of it! For our purposes here, all that matters is what impact it has on the markets, and so far anyway, markets seem happy - US and UK indices having now recovered the late-Oct pre-election dip. That stands to reason, as some traders might have moved into cash, and are now returning to the market once the election result looks (almost) settled.
QE - I saw on the news this morning that the Bank of England's magic money tree has created another £150bn in order to buy up more Gilts. As before, one arm of Government buying up the debt being issued by another. What a clever wheeze! It's working because all the major currencies are doing the same thing, so there's nothing for sterling to devalue against.
This takes the total purchases of Gilts (UK Govt bonds) by the BoE to £875bn. Ian King said on Sky that this is about a quarter of all UK Govt debt. But it looks more like c.45% of all debt, since the figure I've seen is that total issuance of Gilts is around £2 trillion. So I'm not sure what denominator he was using instead of £2 trn?
Where is all this money ending up? From what I'm seeing in the small caps world, the answer seems to at least partly be that it's being hoarded by companies on their balance sheets.
Here's the latest chart from the Bank of England for QE below. All of this is perplexing - conventional economics says that money printing triggers inflation, and ultimately hyper-inflation. That's not happened this time. How it all ends up, nobody knows. But at least in the short term, we don't seem to have anything to worry about regarding inflation or the size of the national debt. Plus of course the debt is being issued at negligible interest rate cost, with interest rates pegged artificially low at just 0.1%. Crazy times, but it's actually working fine, for now.
So far, all the enormous costs of covid are being met by QE. So there's actually not any need to raise taxes at all, because the deficit is likely to shrink rapidly next year of its own accord, as deferred taxes start to roll in, and the employment support scheme costs wind down. If there's any remaining shortfall, then just do another £100-150bn of QE to plug the gap!
I don't think QE will ever be unwound. The relevant debt just vanishes on expiry. This leads me to the conclusion that total UK Govt debt, is actually about £1.2trn, around 60% of GDP, which is historically fine. Plus it's getting cheaper as old Gilts expire, and are rolled over into new, ultra-low interest rate Gilts. So why are so many commentators panicking about the national debt, when it's quite modest after taking into account QE, and super-cheap to service?
Meanwhile permanently low interest rates (which might even turn negative maybe at some stage?) is good news for equities. In particular, I think we are overdue a re-rating of companies with high cashflows, able to pay out generous & rising divis. I'm increasingly directing my money towards companies with good dividend paying capacity in future (not necessarily reflected in the current yield). I think if you can find a reliable 4% yield (or more), from a business that is growing, and in a decent sector, then that could be a great place to be, as we not only collect in the divis along the way, but the shares could re-rate, as other investors chase the yield too, giving profit and income.
.
.
Agenda - these are today's results/trading updates we're taking a look at. As you can see, it's a day dominated by updates from retailers, my sector specialism, so obviously I'll be looking at those first;
Zoetic International (LON:ZOE) - update, and Director buys (Jack - done)
Superdry (LON:SDRY) - Trading statement (Paul - done)
D4t4 Solutions (LON:D4T4) - Contract wins (Paul - done)
Joules (LON:JOUL) - Trading update (Paul - done)
Dfs Furniture (LON:DFS) - Covid-19 update (Paul - done)
Works Co Uk (LON:WRKS) - Half year trading update (Paul - done)
N Brown (LON:BWNG) - Interim results (Paul - done)
Zotefoams (LON:ZTF) - Trading update (Paul - done)
Pci- Pal (LON:PCIP) - AGM update (Paul - done)
Headlam (LON:HEAD) - COVID-19 operational update (Paul - done)
Wincanton (LON:WIN) - Half year results (Paul - done)
Other possibles, depending on time available are:
Kin And Carta (LON:KCT) - FY results - I'm flaking out now, sorry, so this one is abandoned.
.
Timing - lots to look at, so it'll be an all day job I think - let's say 5pm finish time. Update at 14:22 - this is taking longer than expected, so I'll just keep going until I flake out! Hence finish time unknown. Update at 22:40 - I've covered as much as possible now, so today's report is now finished.
.
** The following section is written by Jack Brumby **
Zoetic International (LON:ZTU)
Share price: 38.5p
Shares in issue: 195,570,034
Market cap: £75m
Something a bit different today: Zoetic International (LON:ZOE) -
Zoetic International Plc. is a United Kingdom-based vertically integrated cannabidiol (CBD) and natural resource company. The Company is seeking to acquire and develop feminised hemp seeds as well as manufacturing and retailing CBD brands. The company sells a range of products in the United States (US) and the United Kingdom (UK) through its Chill and Zoetic brands. The Chill brand is a tobacco alternative selling smokables and chew pouches, and the Zoetic brand is a supplier of CBD oils and is also focused on developing and offering range of cosmetics and beauty products. In addition to its CBD operations, the Company also has a portfolio of natural resources projects and holds an interest in the Colorado Shale.
Over in Canada and other markets there has been an absolute boom in cannabis-related stocks, powered by relaxing regulation. Such an environment can cause too much hype and attract story stocks, which could be the case here - note the strong share price in relation to years of operating losses:
It’s an interesting chart, with increasing buying volume - so something must be happening here - but the operating track record makes me wary. We can see at least some of the recent buying volume is coming from the community on Stockopedia though, so I’m keen to explore this one a little further.
Update on Sale of DTU and Kansas Nitrogen Assets
Zoetic International plc (LSE: ZOE), the London-listed vertically integrated CBD company, has reached a revised agreement to sell its 75 per cent interest in DT Ultravert ("DTU") to Path Investments plc ("Path"), as previously announced on 27 May, 8 July and 3 August 2020 (the "Transaction").
Terms are as follows:
- The issue by Path to Zoetic of 30,000,000 new ordinary shares of 0.1 pence each in Path ("Path Shares") on the re-admission of Path Shares to the standard segment of the Official List maintained by the Financial Conduct Authority and to trading on the Main Market of the London Stock Exchange;
- Path will no longer issue 15,000,000 warrants to subscribe for Path Shares at any time from the first to the third anniversaries following completion at an exercise price of 0.75 pence per Path Share;
- Zoetic will no longer be selling its Kansas Nitrogen Assets to Path;
- Path will no longer pay a royalty to Zoetic on future revenues from DTU;
- Path will pay £42,000+VAT in cash to Zoetic on completion towards its professional and technical costs;
- Zoetic will no longer enter into an orderly market agreement in relation to any of its Path Shares; and
- The long-stop date for the Transaction will now be 31 December 2020.
In addition to the consideration elements set out above, Path will issue to Zoetic 15,000,000 warrants to subscribe for Path Shares at any time from the first to the third anniversaries following completion at an exercise price of 1.5 pence per Path Share.
The Company remains committed to its policy of exiting its legacy natural resources activities and the Directors will actively pursue alternative solutions in relation to the Kansas Nitrogen Assets.
Trevor Taylor, Co-CEO of Zoetic, commented, "We are committed to achieve the best deal possible for our shareholders, and we believe that the revised Transaction with Path is an example of this."
Conclusion
Clearly much is changing at Zoetic. Such a dramatic pivot in strategy can be alarming, but I note two directors bought a combined £390,000 of stock just a couple of days ago.
This was on the same day (28 October 2020) as Zoetic’s most recent trading update, in which the company announced
‘a significant order under one of its existing distribution contracts to roll out stock of its Chill range of tobacco-substitute CBD products in a number of convenience store outlets throughout the USA.’
My university days were a couple of years ago now so I’m a bit rusty here but I’m sure this is a big market. That’s potentially quite exciting if Zoetic is crossing the point from product testing to successful commercialization.
At the end of the day, this is a hotly-traded CBD stock, with Spreadex listed as one of its major shareholders and a dearth of institutional holders. Volatility is to be expected and it’s no surprise the stock comes with a Highly Speculative RiskRating.
This is not an area I know well, and I’m wary of the hype. Zoetic is interesting though and I might take a closer look in future to assess the quality of its products and quantify the scale of the commercial opportunity.
A market cap of £75m is already pricing in quite a lot of successful execution, and all I see right now are the historic operating losses. There is also a history of significant equity dilution here.
On balance, the financial health scores are positive and the director buys are intriguing enough to warrant a closer look but I’m yet to be convinced. If others are more familiar with this stock and would like to offer the bull case, I’m certainly willing to listen.
.
Superdry (LON:SDRY)
Share price: 155p (down 7% at 12:08)
No. shares: 82.0m
Market cap: £127.1m
Here are my quite detailed notes from 21 Sept 2020, where I reviewed the results for FY 04/2020. I explained then why I was bearish on this share;
- It was loss-making before covid started
- Losses likely to be huge this year FY 04/2021
- Locked into ruinously expensive shop leases - it needs to do a CVA to jettison these millstone shop leases
- Adequate liquidity for now, but looks likely to need a substantial fundraising in future
- No sign of “brand reset” strategy working yet - talk is cheap
- Tired brand, past its prime?
As always though, nothing is set in stone. So if the figures improve, and the turnaround under the original founder, Julian Dunkerton, begins to gain traction, then I reserve the right to turn positive on the share. After all, as investors we have to follow (and anticipate) the facts & figures, emotions mustn’t come into it. Changing our minds when the facts change is vital.
Today’s update is for H1 in FY 04/2021
Superdry today announces a trading update covering the 26-week period to 24 October 2020 ("H1 21", "H1" or "the period").
As you can see from the table below, Q2 figures (Aug, Sept, Oct) are barely any different to H1 total (May, June, July, Aug, Sept, Oct). That’s bad, because of course the May & part-June figures would have been in lockdown, with stores closed. In other words, they’ve been re-opened in Q2, but total sales have barely changed from Q1. Note that online growth has slowed in Q2, as some sales moved back to the stores. All in all, these are bad numbers in my view;
.
.
Recent trading - not good -
Like-for-like store trading in the last six weeks of H1 was (32.4)%, with UK trade impacted by continued social distancing measures, partially offset by stronger performance in Europe where footfall declines have been less severe.
About half its stores have now closed again due to the England lockdown. Although remember that the staff costs can be recouped under the new temporary furlough scheme, and of course no business rates are payable this year.
E-commerce sales have been decent in the last 6 weeks -
Ecommerce is performing well and strengthened through Q2 21, with like-for-like sales up 51.9% in the last six weeks of H1. The improvement was driven by owned site sales, which increased 68.9% year-on-year coinciding with the launch of our new AW20 product and the targeted clearance of aged stock.
Gross margin - this is a key element of the turnaround plan - i.e. to raise gross margin by selling more at full price. I’m very sceptical about this, and it seems that scepticism was well-placed;
In response to Covid-19 we have increased promotional activity to clear excess inventory, reducing full price mix2 and Retail gross margin in the first half. This has been partially offset by the continued focus on both cost management and the cash preservation actions beginning in late FY20. Given the continuing disruption, we expect these margin dynamics to continue for the remainder of FY21.
Poor sales, combined with a poor gross margin, and largely fixed costs, is a really toxic combination, usually resulting in heavy losses.
The brand reset remains on track, despite the current unprecedented levels of disruption and volatility.
Really?! The poor sales & gross margin suggest the opposite.
we are focused on maximising revenues over the Black Friday trading period from Ecommerce. We have in place commercial and operational plans to capture the expected elevated demand online across this important period.
They haven’t really got any other options, since many of the stores have had to re-close today. I’m not sure what proportion of sales are online, but it’s not as high as say Next (LON:NXT) or Joules (LON:JOUL) which do half or more of all sales online. That is such a key element, and personally I’m only interested in backing retailers that have cracked online selling, at about half (or more) their total sales.
Liquidity - looks OK for now -
At 3 November we have a net cash balance of £22.2m (2019: £(16.4)m) as well as access to our recently refinanced and currently undrawn borrowing facilities.
This is down from net cash of £36.7m at 21 Sept 2020.
The undrawn facility is a £70m asset-backed lending facility, available until Jan 2023, so just over 2 years for that, hence no immediate crisis.
Outlook comments are largely waffle.
My opinion - there’s no sign of recovery here at all. Revenues are weak, and not improving, despite the ending of lockdown in Q2. Gross margins are under pressure. There’s nothing said about how the new A/W ranges are doing - remember this was meant to be the start of the turnaround, therefore I can only conclude that they’re not selling as well as hoped, which means discounting will be needed to clear the stocks in due course, especially after the latest lockdown has wiped out a month's sales. It needs a monster Dec & Jan sales trading period, but how can that be done with social distancing?
Liquidity looks OK for now, but the business is undoubtedly trading at heavy losses, which burns through cash. Therefore I reckon a big fundraising is likely to be needed in 2021. If that’s combined with strong sales growth, and signs of progress in resetting the brand, then it should be able to raise the money. If sales are still poor, and no sign of a turnaround, then investors may require a deep discount to keep the company afloat in 2021.
The obvious solution is a CVA, to ditch the problem store leases, some of which are expensive flagship type stores in city centres. I’m told that SDRY has managed to secure some rent reductions, but that’s usually only possible for leases that are coming up for expiry or break clause. As you can see from the last balance sheet, the existing lease liabilities are very high. Why would investors want to pour in fresh equity, just to keep the landlords happy?
I’ve no doubt that management & team are deeply passionate about turning things around. That takes time, and money. There’s no sign at all of it working so far, and the money is running out. For these reasons, this share is little more than a hopeful punt at this stage. It’s very similar in that respect to Ted Baker (LON:TED) . I wouldn’t touch either, unless tangible evidence of a strong turnaround becomes evident from the figures. Until then, it’s just wishful thinking.
Note how the broker forecasts are continually being reduced, and the forecast loss for this year FY 04/2021 still looks way too optimistic to me. My rough workings suggest a considerably larger loss for this year. Next year - who knows, the situation is too uncertain to be able to forecast sensibly that far out.
.
.
D4t4 Solutions (LON:D4T4)
Share price: 214p (up 10% at 13:12)
No. shares: 40.22m
Market cap: £86.1m
This is interesting, because it’s relevant to a recent trading update, indicating contract wins deferred from H1 to H2. I covered that here on 21 Oct 2020. To summarise that, D4T4 only did £5.1m revenues in H1, and needs to achieve more than 3 times that figure in H2, just to hit forecast for FY 03/2021 of £22.9m revenues. Clearly a tall order. Also, the shares are expensive (PER of 29), even if that ambitious forecast is met.
Today it says;
"D4t4"), the AIM-listed data solutions provider, announces four new contract wins in key vertical sectors for the Group's Celebrus family of products, which will add a total of c£5.5 million to revenue in the current financial year. These wins evidence the strength of the pipeline of business opportunities with new and existing clients alike that is underpinning the Board's confidence in delivering a strong second half of the year….
Some more information is given, but not client names, but they sound like big companies.
Outlook -
"We are in a good position and remain confident about our prospects for the full year with clear visibility on both existing and new business, plus the high level of recurring revenue to be recognised during the second half."
Finncap is very helpful, in making its research notes available to us (directly, or via Research Tree). There’s an update today, which reiterates what it said in Oct, that there’s another £8m in recurring revenues already secured in H2, on top of the £5.5m contract wins announced today. Therefore, most of the sales needed in H2 are already in the bag. This raises the prospect that D4T4 might actually meet, or exceed the forecast for this year (Finncap has £21.7m revenues, and 6.6p forecast for this year.
My opinion - it’s not cheap on a PER basis, but I’m a lot happier that forecast figures look achievable, after today’s announcement. Another boost to the credibility of management outlook comments, as we discussed last time.
This share looks increasingly interesting. I don’t understand what it does, but do realise that data is very important, and seems to be a thing of the future. Big companies are buying D4T4’s software/services, so it must work well for them.
Overall, I like the look of this. Although shareholders have to live with lumpy contracts, hence limited visibility at times, especially during H1 periods, it seems. That makes the share rather tricky to value.
.
Joules (LON:JOUL)
Share price: 105.6p (up 5% at 14:03)
No. shares: 108.4m
Market cap: £114.5m
Joules, the premium British lifestyle brand, provides a business update in light of the latest UK Government restrictions, as well as an update on trading in the financial year to date (the first 22 weeks of its financial year to 31 May 2021 or the "Period").
All England stores now closed, with staff going onto furlough. No surprise there, that’s obvious.
Wales stores re-opening on 9 Nov, whilst Scotland & N.Ireland currently remain open.
Online sales - this is important, because Joules has historically sold around half online, and that’s likely to be much higher now;
The Board believes that Joules remains well positioned to satisfy higher anticipated online demand over the forthcoming peak trading periods, having completed several capacity and efficiency enhancements within the Group's UK warehouse during 2020.
Current trading (before lockdown 2.0 anyway) has been good;
The encouraging trends reported in the Group's trading update on 23 September 2020 have continued, with sales for the Period remaining ahead of the Board's expectations. This has been driven by strong year-on-year e-commerce growth of 35%, with e-commerce revenue accounting for 70% of the Group's retail sales in the Period.
The Group's stores performed ahead of the Board's expectations during the Period, with sales since the re-opening of Joules stores in July down by 18% year-on-year.
The Group's wholesale and international sales have performed in line with expectations over this Period.
70% of sales online, wow. Should we start to see this as an online brand, that happens to have some shops too? Should they wind-down the physical stores, and move online only, I wonder, or just keep a few physical stores to maintain a brand presence?
They clearly “get” online, which is so crucial for success these days;
The Group's active customer base has now grown to 1.5 million, reflecting the strength of the Joules brand. 'New to brand' customer growth has been particularly strong in recent months, benefitting from: focused digital marketing investment; the positive impact of the Friends of Joules digital marketplace; and the desirable lifestyle locations of many of the Group's stores.
Liquidity - sounds fine;
The Group's balance sheet remains strong with net cash of £9.4 million and liquidity headroom of £57 million at 1 November 2020.
Outlook - impressive. How many retailers are confirming full year expectations?! Albeit considerably lowered expectations;
As a result of Joules' continued momentum, and notwithstanding the significant levels of uncertainty as the Group enters the critical peak trading season, the Board believes that Joules remains on track to deliver its expectations for the FY21 financial year.
My opinion - what a pity this announcement didn’t tell us what management expectations are for current year trading? Those footnotes are so useful, when companies/advisers do remember to include them. Hence without knowing what their expectations are, I cannot value the share.
That said, I think it’s becoming increasingly clear that Joules might be one of those shares to just buy and tuck away for the long term, on the basis that it’s demonstrated strong flexibility this year, and it’s a brand, not just a retailer. Hence the customers seek it out online, whether the shops are open or shut. That’s very valuable.
Overall then, I like it, and will add it to my watchlist. This strikes me as a vastly better investment proposition than hoping for a turnaround at Superdry (LON:SDRY) .
.
Works Co Uk (LON:WRKS)
Share price: 22.0p (up 31% at 15:40)
No. shares: 62.5m
Market cap: £13.8m
TheWorks.co.uk plc, the multi-channel value retailer of gifts, arts, crafts, toys, books and stationery, today announces a trading update for the 26 weeks ended 25 October 2020 (the "Period" or "H1 FY21").
This is an interesting update.
Since re-opening, the stores are trading level with last year (very good in the circumstances), and online has doubled. That gives total LFL (including online) of +10.6% - good going.
If my numbers are right, that means we can deduce that last year online was about 10% of total sales, and has risen to about 20% of total sales this year - going in the right direction, fast, but still not a madly exciting level of online activity. As mentioned earlier in the report, ideally I’m looking for retailers that can get to 50%+ of total sales online, like Next (LON:NXT) and Joules (LON:JOUL) (now up to a remarkable 70% online).
Liquidity is good for now, with £8.4m net cash, although that includes £4.0m of favourable working capital temporary benefits. It’s not clear if this includes tax payments deferred or whether those are additional benefits?
Outlook comments sound cautious but optimistic! There’s no profit guidance;
Due to the Group's strong financial position on entering this period, the Board is confident that the Group has adequate resources to support the business, whilst retaining headroom within its banking facilities. In light of the high level of uncertainty, the Board will not be issuing profit guidance for the full year FY21 at this time.
My opinion - this is better than I expected, but it doesn’t actually tell us anything about profitability. That and the lack of guidance, and no broker notes, means I can’t take this idea any further.
I’ve previously held a few shares in this, but ditched them at some point earlier this year, when I had to cull lower conviction positions in my Spreadex account, due to margin calls caused mainly by Revolution Bars. Such is life.
So the question now is whether I want to buy back into WRKS? It’s tempting, as the market cap is very low, so could it be a potential multibagger in future? It sounds like the risk of insolvency is low at the moment. Also, when I did visit a store over the summer, I liked the products, which are cheap & cheerful, and I always seem to pick up something - cheap books or cards, a jigsaw which I gave to my niece, a map of the world to go on the wall for only £4, etc. So it’s quite a nice format, and high margins are made on those products.
On the downside, it has 530 stores, which needs a big central overhead to manage and I wonder how many of those are now over-rented? So it could be a good candidate to do a CVA, to exit all the problem leases. If it did a CVA, then I would be happy to invest, but for now, I’ll watch from the sidelines. It looks like WRKS should survive, for now anyway, but will it prosper in future? That’s difficult to see at the moment.
Not the best of floats, in July 2018 at 160p, providing an exit for its PE backer, Endless.
.
.
Quick comments from now, as I’m almost out of time.
Pci- Pal (LON:PCIP)
46.5p (up 16%) - mkt cap £27.5m
See our archive here for several sections, where I covered the results in Sept, and decent outlook for reaching breakeven next year. There’s also a very informative management presentation available on InvestorMeetsCompany - in it management explain how the costs are mainly fixed (people), but recurring revenues are rising rapidly. Therefore it’s heading towards breakeven after previous losses.
Today it tells us;
As a result of the strong start to the year in sales and customer deployments, first quarter revenues are 44% ahead of the comparative period last year, with revenue visibility against current market forecasts for the year ending 30 June 2021 now at 88%.
It was previously reported as +41% in July & August, therefore to rise to 44% for Q1 (July, Aug, Sept) means that Sept must have been nearer to +50% growth Y-on-Y. Very pleasing.
I wonder if already having 88% visibility on revenues to June 2021, means that they’re heading for a possible beat against forecast?
My opinion - there’s more info in the RNS today, but suffice it to say that my positive impression in Sept 2020 is getting stronger. This looks a potentially interesting share, I’ll add it to my watch list.
Stockopedia rings the alarm bells - the StockRank system hates loss-making, jam tomorrow type shares!
.
.
N Brown (LON:BWNG)
55.7p (down 6%) - mkt cap £158m
Placing & open offer to raise c. £100m - this is a very significant fundraising, for a company with a market cap of only £158m. The prospectus is here. I do find the requirement for such a detailed prospectus is overkill, and wish the authorities would streamline the regulations to make it easier & cheaper to raise equity. The cost of a prospectus, per person who actually reads it, must be gigantic!
- Moving to AIM.
- New & extended bank facilities, once fundraising done.
- Purpose is to accelerate growth, and strengthen/de-risk the balance sheet - it’s mostly being used to repay unsecured funding, and the CLBILS borrowings, which then removes restriction on paying divis.
- Open offer is 11 new, for 18 existing shares
- Price looks fair, at 57p
- As usual, outrageous costs of £6m
- The deal is supported by its major shareholder, Lord Allliance
This fundraising looks fine to me. It reduces risk, but makes the upside per share less.
Half Year Results - there’s a webcast here.
- H1 revenues down -17.6% on LY, at £356.7m
- Improving trend from Q1 (lockdown) to Q2
- Profitable - adj PBT £22.6m in H1, down 28.9% on LY
- Cost savings, especially marketing efficiency. Being c.90% of sales online, the cost base is flexible, which I like
- No guidance given for full year, but it does say in outlook comments;
- the Group continues to trade in line with the Board's expectations and w e continue to be excited about the opportunity for N Brown to return to growth
- Regulatory pressures on the financial services is reducing margin, and covid has increased customer bad debts
My opinion - this is a strange business, which I tend to view as being like the old catalogue shopping businesses, where they make profits from extended payment terms at high interest. BWNG is just doing that online.
The problem is that every now and then, regulatory problems emerge with consumer credit, which can be expensive to remedy. So it’s riskier than a pure play eCommerce business.
I think there’s a lot of potential here, for decent management to actually make the product side of things grow, and become more decently profitable. Can you imagine what BooHoo could do with this business, if they took charge of it?
It’s very cheap, if you see it as an eCommerce business. Track record is poor, and it’s unimpressive to see revenue shrink so much, when it should have been soaring due to physical competitors being shut earlier this year.
I’m not convinced management are any good yet, but time will tell.
Looks interesting, in my opinion.
.
Dfs Furniture (LON:DFS)
198p (down 2%) - mkt cap £508m
181 out of 208 showrooms are now temporarily closed, due to lockdown measures
Manufacturing & deliveries are continuing as normal - remember there is a lead time on furniture, which helps when lockdowns happen
Current lockdown measures not expected to materially impact profitability for the first half
H1 is July-Dec 2020. However, what it doesn’t say, is that there could possibly be some impact on H2, due to reduced orders taken in November’s lockdown, maybe?
Some business is likely to shift online;
Our websites across all brands and territories remain open for business and are performing well. Based on our previous experience of lockdown we expect our online business to improve further. This will be supported by the temporary transfer of showroom colleagues to other areas of the business, including remotely assisting customers with web purchases.
… Furthermore, our experience of the prior lockdown periods was that substantially all order intake disrupted during the lockdown period was either deferred until showrooms reopened or was captured online.
That was also confirmed by Scs (LON:SCS) (I hold) which recouped all of the lost lockdown sales, in the following few months.
Liquidity - it’s true that DFS has liquidity;
Strong Financial Position
Our balance sheet position remains robust. With the strength of recent trading, helped by associated working capital inflows, we currently hold a net cash position, with access to over £300m of available cash and undrawn bank facilities.
However, it is categorically untrue that it has a strong, or robust balance sheet. The balance sheet is actually extremely weak. To demonstrate that, its last reported balance sheet benefited from an equity fundraise of £63m in April 2020 (42.3m new shares, at 150p each, a 16% premium to the prevailing share price back then). Despite this, NTAV was terrible, at negative £(330.6)m, at end June 2020, which I’ve calculated as NAV of £201.9m, less worthless intangibles of £532.5m.
The working capital position is awful too, with current assets of £155.7m, less current liabilities of £316.6m.
There are over £500m in lease liabilities too, which could be problematic in a prolonged economic downturn.
The business is effectively funded with bank debt, and making use of customer deposits paid in advance of paying the manufacturers to make their furniture. That’s not prudent, and in my view, customer deposits should be ring-fenced. Therefore, DFS takes advantage of favourable working capital characteristics. That is very different from having a strong balance sheet.
Therefore, due to its extremely weak balance sheet this share should be seen as high risk.
My opinion - DFS is uninvestable to me, because of its terrible balance sheet.
Scs (LON:SCS) (I hold) is a far safer, better alternative, in my view. It has a bullet-proof balance sheet, stuffed with cash, no debt, and has traded superbly since lockdown 1.0. It’s on a single digit PER too, with broker forecasts that look much too conservative. Hence ScS is my sector pick.
DFS has not been a good investment, as you can see below. Although it has paid c.50p in divis in the last 5 years, so the total shareholder returns is not as bas as the chart implies.
This share very much remains an investment for people who don't look at balance sheets!
.
.
Zotefoams (LON:ZTF)
419p (down 2%) - mkt cap £202m
5 November 2020 - Zotefoams, a world leader in cellular materials technology, today provides a trading update for the third quarter, ended 30 September 2020.
This seems a good update, concluding;
… the Board expects full-year revenues and underlying profit before tax to be in line with market expectations...
That’s encouraging, but bear in mind that forecast earnings for this year have roughly halved from pre-covid estimates;
.
.
My opinion - neutral. It looks expensive on a PER basis, but it’s good to see a company that confirms full year guidance.
Note that it has had some benefit (not quantified) for making PPE equipment in the covid pandemic.
At this sort of valuation (forward PER over 30), it’s going to have to beat forecasts next year, not just meet them.
.
Headlam (LON:HEAD)
264p (up 3.5%) - mkt cap £224m
This carpet/floorcoverings distributor, gives us a brief update today, saying;
- All sites to remain open
- Fulfilling customer orders as normal
My view - clearly that’s encouraging, but it perhaps glosses over the risk that customer demand is likely to reduce, because the customers’ retail premises will be closed for about a month. So the question is, how much of a downturn is HEAD likely to see in demand, and how quickly would it pick up, when pent-up demand returns?
I’m not overly worried about this, because HEAD is the type of company that is benefitting from the trend to make home improvements. So any slippage of business due to lockdowns, is likely to be recouped.
Apparently there’s a shortage of skilled carpet fitters - an opportunity for out of work people to re-train, possibly?
I don’t currently hold HEAD, as unfortunately a recent attack of margin-itis, forced me to cut a few geared positions, to fund the losses on other things. But HEAD is very high on my list of things I want to buy back into, when funds permit. It’s a good recovery share, and looks cheap if you look forwards say 2 years. Also the balance sheet is wonderful, with a ton of freehold property - in for free, I would say.
.
Wincanton (LON:WIN)
230p (up 1%) - mkt cap £287m
The story for this logistics company has been getting better of late. Here are my notes from 2 Oct 2020 trading update, including an important improvement in the pension deficit situation.
Wincanton has traded surprisingly well this year, with increased eCommerce business and business from the supermarkets, seemingly offsetting some of the downturn in business from some other retailers. Whatever happens with lockdowns, people still need to be supplied with things.
Considering the chaotic year we’ve had, these numbers for H1 (April to Sept 2020) look pretty respectable to me. Obviously down on last year, but looking resilient I think;
.
Note in particular that it’s paying a divi still, when many companies have cut them. Also, the free cashflow figure looks huge, and it’s moved into net cash. No doubt some creditor stretch has helped in that regard. Yes, here it is;
Strong improvement in cash to deliver net cash of £63.3m (2019: net debt of £(14.8m), driven by good working capital management and deferral of VAT, corporation tax and pension payments… mainly due to the deferral of £43.9m of VAT payments in the first quarter, but also due to continued strong disciplines around billing and cash collection throughout the period.
Strong current trading & positive outlook;
Good momentum into H2 - results for FY20/21 expected to be materially ahead of current market expectations assuming no further severe impacts from COVID-19
The pension scheme is massive, so careful research still needs to be done on this. What would happen if interest rates turned negative, or if asset values collapsed?
.
A reminder that the deficit recovery payments are still very material to the valuation of the company. Hence this share should be on a low PER;
The annual deficit funding net contributions have been agreed at £18.9m per annum from 1 April 2021 increasing by RPI over the three years to March 2024, followed by £22.0m per annum from April 2024, increasing by RPI to March 2027. The Group will continue to pay certain administration costs directly and, in line with the Schedule of contributions, these will be deducted from the deficit funding contributions….
As at 30 September 2020 the Scheme's investment was split between 17% in return-seeking assets and 83% in defensive assets.
Potential tax liability - I don’t like the sound of this, as it creates uncertainty & potentially a large loss;
The Group has been notified by HMRC of potential claims for Excise duty and related VAT in connection with the historic transfers of a group of former customers' excise goods. These movements occurred from one of Wincanton's bonded warehouses to a common third party UK export agent. HMRC suspects irregularities to have occurred during the export process and the export agent has subsequently entered administration. Due to the nature of the excise regime Wincanton operates in, HMRC considers Wincanton to be jointly and severally liable for Excise duty and VAT arising as a result of these irregularities.
Wincanton is vigorously disputing the potential claims and is confident in its legal position having received clear, expert advice. As a result of the strength of the legal advice, no liability has been recognised in respect of these claims, noting that the total value of the potential claims could be up to approximately £50m before interest and legal costs. We expect that any claims made by HMRC will be received in the second half of the year.
Unless earlier resolution is achieved, the Group expects to proceed to have the claims heard before a Tax Tribunal and the full legal process could take in excess of two years. Under current regulations, some or all of the claims could be required to be paid shortly after issuance and in advance of the outcome of a Tribunal. The Group is in discussion with HMRC regarding the process and potential options to minimise the risk of cash outflows in advance of a Tribunal. In parallel with the legal process, the Group is reviewing options regarding its insurance cover.
Balance sheet - overall, it’s still weak. NAV is negative, at £(28.4)m. If we deduct £86.2m worthless intangibles (goodwill, etc), then NTAV is unpleasantly negative, at £(114.6)m.
A bit like DFS above, WIN can operate fine with a weak balance sheet, because it gets money up-front from customers. But that doesn’t alter the reality that its balance sheet is weak. It may not particularly matter, when things are going well, but a weak balance sheet means there’s nothing in reserve, if something goes wrong. Look how DFS had to raise fresh equity, at the height of the crisis earlier this year.
That £326m trade payables on WIN’s balance sheet really jumps out at me as looking very high indeed. Also, the strange rules on pension scheme accounting, seem to allow WIN to show its pension deficit as an asset on the balance sheet, of £24.3m, which is crazy when the company is actually having to make large payments into the pension scheme to recoup the actuarial deficit. Therefore the real world NTAV is a lot worse than shown above, the way I look at things.
My opinion - this seems a really good business, that has traded relatively well in 2020, given the problems. However, when you dig into the numbers, it’s financially very weak. Liquidity is fine, but the business is financed on shaky foundations, in my view.
The need to pour money into the pension scheme means divis are likely to be limited, and I think it’s very unwise for the company to resume divis when its NTAV is heavily negative.
On the upside, a lot of investors may just ignore the weak balance sheet (as with DFS). So the share price could continue recovering, if its trading updates continue to be good.
.
Phew, that was a busy day! I have to leave it there for now. See you in the morning.
Best wishes, Paul.
Disclaimer
This is not financial advice. Our content is intended to be used and must be used for information and education purposes only. Please read our disclaimer and terms and conditions to understand our obligations.


78 comments
For anyone interested in the US election, Biden is now ahead in both Georgia and Pennsylvania, if that stays the same then he will have a fair majority. As the margins are small there are bound to recounts and legal challenges, so expect some volatility in the markets but they are pretty calm at the moment, surprised how much they went up in the last few days.
All countries are debasing their currencies. This shows up in the huge asset inflation we've seen the last decade.
Anything that is useful as a store of value will continue to hold its purchasing power
- Gold
- Stocks
- Prpoerty
- Scarce collectibles
- Provably scarce crypto currencies - ie Bitcoin
Government borrowing seems fine while the public stay relatively quiet about asset inflation or until it seeps into CPI. If we see inflation across wages and consumer items or asset inflation increases pace - all hell breaks loose and central banks and governments have a hard time keeping interest rates at low levels.
It's a confidence trick. It's all fine until the dam bursts. Which it will eventually :-/
Joules (LON:JOUL)
Hi Paul
Just a quick addition to your commentary.
70% of RETAIL sales are now e-commerce.
So retail revenues for H1 look likely to be £79m vs £80m last year.
However, a note of caution. As far as I know the company has not released any figures on their Wholesale or Marketplace channels, which accounted for £32m in H1 last year, so quite a big chunk of the business.
Without these figures it's very hard to work out how much cash the company is actually generating, or burning.
No position (yet)
A
Pci- Pal (LON:PCIP) MCap is £24M so if sales continue to grow at anything like the current rate and costs remain at anywhere near their current level the StockRank will soon tell a very different story. My response to johnthetourist below suggest why they should achieve this.
The proposed 57p open offer at N Brown (LON:BWNG) (no position) is perhaps the start of a worrying trend allowing control of companies needing refinancing being bought without a premium being paid. This follows the recently announced open offer at Countrywide (LON:CWD) (tiny position), where Alchemy is gaining control at below market price. As arguably non-exec chair David Alliance (33.81% stake) already has a significant influence at N Brown (LON:BWNG) and is taking on some risk perhaps this deal is easier to justify.
N Brown will raise £100m through an open offer - effectively fully underwritten by David Alliance, which if used would increase his stake to 58.9%. Deal needs approval from independent shareholders and the waiver of rule 9 (which otherwise would require Alliance to bid for 100% of the company). The deal also has a couple of odd points that might be of wider relevance:
Hi wimbledonsprinter,
I'm not sure I agree with your take on things. The BWNG fundraising is being done at a pretty good price, compared with what might have happened in a distressed fundraise back in April - maybe 10p per share, and massive dilution?
It seems to me that having a key major shareholder can be a very good way to protect shareholder value, as they want to preserve the value of their existing stake, and not look daft. With fund managers, it could be seen as buying them time to find another job, whilst they prop up their bad investments! Or is that too cynical?!
Regards, Paul.
Paul
I agree it depends on the situation - but Rule 9 of the Takeover Panel Code is there to protect minorities and I do worry it seems that shareholders are being asked to waive it seemingly more and more regularly - admittedly shareholders do get a vote to waive.
There was also the extraordinary situation at Scancell Holdings (LON:SCLP) who raised £33m this month. 29% shareholder Redmile was offered 2 year 3% coupon convertible bonds at the same conversion price (13p) as shareholders were in the open offer - despite the advantages the convertible offered. It also allowed Redmile to increase its grip on the company without going over the 29.9% limit forcing it to bid for 100% of the company. [Conversion would result in Redmile owning 43% of Scancell.]
As a connected party transaction, the convertible issue to Redmile needed the support of the minority shareholders as a special resolution. On the day of the GM, the board realised they did not have enough votes - as one of the large shareholders had voted against. The board decided to postpone the GM by a week, while scurrying around to get the extra votes it needed - and all the motions were duly passed yesterday. This also highlights the potential conflicts of boards, when they are not disinterested parties, being in charge of the organisation of the votes.
I have a smallholding in N.Brown, and I would like to know from more wise men if I should take up the offer? The price is currently 54.20p so I could buy it cheaper than take up the offer? Is this correct? I may be wrong, so some advice would be greatly appreciated
PS the offer is 57p and the buy price is currently 54.8p
Hi Paul,
Hope you're very well.
I know you have access to Research Tree - Have you looked at the difference between the Liberium forecasts and the ones on Stockopedia ( for Joules (LON:JOUL) ).
The case for investment seems a no brainer based on the Liberium Rev/PBT/EPS forecasts (if they are met), yet it is much less attractive if you look at the forecasts on Stockopedia. This is the case even if you look back to the Liberium September note instead of todays (as it is little changed).
Appreciate your thoughts if you get a chance to compare them and I wonder why there's such a difference.
Cheers!
Jon
Hi Jon,
Thanks for flagging up the Liberum note on Research Tree, I hadn't spotted that.
Liberum are forecasting 3.6p for this year, FY 05/2021. Whereas Stockopedia (Thomson Reuters data) is showing broker consensus of 7.9p. That seems at odds with your comment.
For the following year, FY 05/2022, Liberum forecasts 6.7p, whereas Stocko says 6.45p - not much difference.
So I don't really understand your point.
I'm really impressed with how JOUL is handling this extraordinary year, and it's a share which I am inclined to almost ignore this year's trading, and think of it more as a long-term investment.
Although at the moment, I think there's possibly better upside on some other things. In particular, I'm seeing Saga (LON:SAGA) (I hold) as a potentially quite big multi-bagger, once the cruise ships are sailing again, maybe Q1 or Q2 in 2021?
Also of course there's Boohoo (LON:BOO) which I find highly attractive at this level.
I'm also a recent convert to Redde Northgate (LON:REDD) which looks terrific value.
Therefore, to me JOUL looks good, but the others look better.
As always, just my personal opinion, and as you know me quite well, I get plenty more speculative things wrong! But the odd big winner sorts everything out.
Best wishes, Paul.
Hi Paul,
Thanks for the reply, much appreciated, I too hold Redde Northgate (LON:REDD) - Initially brought to my attention by Richard Leonard on PI World.
Regarding Joules (LON:JOUL) I was indeed more so looking at the EPS, which doesn't show a dip (to negative) in the Liberium note and that the growth from 2.8 (20A) to 3.6 (21E) to 6.7 (22E) to 9.2 (23E) looks very attractive - For a low double digit forward PER for a mostly online business. I ended up taking an opening position yesterday.
Interesting to see the US website traffic up 2x in the past 6 months - https://www.similarweb.com/web...
Thanks again and have a great weekend.
Jon
The furlough scheme has been extended to the end of March next year. That suggests to me a much longer lockdown than just four weeks, a planned vaccine around or just before the new furlough expiry date and other measures will follow (the stamp duty freeze will be extended is my guess). Online stocks will probably continue to do well and it gives a lot of clarity for many. I suspect that unemployment will continue to grow but the rate will slow.
Gold may have a huge rally in time as the money printing presses work overtime. The latter has got to be good for De La Rue (LON:DLAR) a core holding for me. Bitcoin has already raced up to nearly $15,000. Wow.
The bio stocks are flying as takeovers increase; Arix Bioscience (LON:ARIX) has soared today on a takeover of one of its holdings. A lot of this new cash will inevitably flow into the markets in my view with zero interest rates the alternative.
The ftse100 futures hit a low of exactly 5500 early Monday morning. Now at 5900, the UK market is still very cheap compared to many overseas markets. Everything seems very bullish.....very strange bearing in mind we are on day one of lockdown and totally different to the first time we went into lockdown.
barnetpeter any views on the value of Arix Bioscience (LON:ARIX) post this sale to Merck? Seems Arix will receive funds equivalent to their market cap at the new SP of 160p - so everything/anything else in for free?
Arix Bioscience (LON:ARIX) - Per RNS - The sale of VelosBio is expected to deliver net proceeds to Arix of approximately $185 million (£142 million[1]), representing a 12x return on Arix's £12 million invested capital. This equates to a £121 million (89p per share) increase in the gross value of Arix's holding in VelosBio of £21 million[2].
Pre Announcement price 108
Incremental Cash to be realised from sale (i.e. over and above fair value @ 30.6.20) +89p (Fair Value c and p below )
Post Announcement - should be 197
Interesting...
Thanks for raising this.
Just noticed - Revision to my figures will be required to account for corp tax @ 19%
Hi barnetpeter,
Just to be pedantic, but QE "money printing" would not have any impact on De La Rue (LON:DLAR) either way, as the new money is created electronically, there's no actual money printing.
Regards, Paul.
Tend to agree with the comments about QE:
"It's working because all the major currencies are doing the same thing, so there's nothing for sterling to devalue against."
Which is why I'm reasonably bullish about the prospects for Gold, at least as a store of value. There's also the prospect of a currency race to the bottom with devaluations designed to give domestic companies a competitive edge. Purely conjecture, but I suspect that many investors regard this low interest rate environment as normal. While a quick glance at a chart shows that it's anything but normal. Where this will end up is anyone's guess.
re Works co uk (LON:WRKS), I was in one of their stores a couple of days ago, it looked busy, as it jolly well should be given that they will be closed for at least a month from today. It seems to be filling a gap on the high street which has been mostly vacated by W H Smith - I suspect their real competition is independents, who will often operate off high street from cheaper premises. But . . . what is the true level of gearing? At a quick and inexpert glance, if you strip out lease obligations, net debt still looks high against book value, which in turn holds a fair chunk of intangibles. It looks like not enough equity to me. I don't hold.
I would suggest that the increased trading volume in Zoetic International (LON:ZOE) is, at least in part, because it is getting a lot of coverage in TA chat rooms and on Twitter too.
D4t4 Solutions (LON:D4T4) appears to have delivered on its second half weighting, as it has done in the past. There are never any guarantee's in life, particularly in stock market investing, but it is always reassuring when management does what it said it will do.
Also interesting announcements from Headlam (LON:HEAD) and Ramsdens Holdings (LON:RFX) in that they will continue to trade during the current lockdown.
In my view Headlam (LON:HEAD) is a well managed financially robust business. It completed the state of the art distribution centre in Ipswich on budget and is in the process of consolidating some regional distribution centres into the former. It is also in the process of streamlining its logistics and transport facilities. The consolidation will result in a number of site closures. The freehold sites at Hadleigh and Bedford are to be sold. The lease terminates on the Dartford site this November with the potential termination of the lease on the Chelmsford site in the second half of next year.
I agree with the earlier comments by rmillaree and Brookeda on Ramsdens Holdings (LON:RFX) and H & T (LON:HAT), although the latter still awaits the conclusion of the FCA review of its credit worthiness and lending processes for certain unsecured loans, which have been discontinued.
I hold shares in all of the above, so have a natural bias and have this morning added to £HEAD. As always DYOR.
Best wishes to all
Hi jonno, thanks for this comment, you've prompted me to add D4t4 Solutions (LON:D4T4) and Headlam (LON:HEAD) to my list. I think both look interesting too.
Best wishes, Paul.
D4t4 Solutions (LON:D4T4) is a holding of mine and has been for some time. In general I'd say that when management say they expect to hit 2nd half they do, and so I have a lot of confidence in their projections. Over the last 3 years it seems to me as though they have a very good handle on what they will achieve during the year but not so much control on when that will land within the year. Thus I think as an investor I have to ignore H1/H2 type extrapolations and instead focus on management outlook and year end results. This has proven a far more reliable indicator on this share so far.
Many thanks Paul
I look forward to your thoughts.
Keep well.
Best wishes
The realisation amongst investors that H & T (LON:HAT) was indeed permitted to trade in lockdown came later in the morning when the SP jumped as much as 16%+ . To be fair, the SP had drifted to its 4 yr low when it was in its doldrums in the past week at around 200-210 area, with PIs expecting deterioration in trade due to c19 + possible lockdown. I hold.
Whoops me bad - SP jump due to RNS at 11am rather than investor realisation (cross reading from Ramsdens Holdings (LON:RFX))!
I have a very general question (apologies in advance) - does anyone know if there a convention as to what constitutes "strong double digit growth" in RNS announcments?
ie. does this conventionally mean 15% plus, or is it as ambigious as it sounds?
Thanks in advance for any thoughts!
I call 15% strong because if earnings were to grow at that rate every year for 5 years they will double.
H & T (LON:HAT) just issued an RNS, "ahead of market expectations", so very timely thoughts rmillaree!
Bit naughty of H & T (LON:HAT) - releasing an rns at 11.00am (well after most of us have scanned through companies that we hold or are interested in).
Reads well though and am happy to continue holding.
I would agree not impressive for H & T (LON:HAT) to release an important update at 11am. The statement is positive though - stores remaining open, retail sales are strong as is the gold price and no mention of bad debts, whilst net assets now equates to 353p, valuing H&T at 0.63x book value, which looks cheap. Share price now up 11%.
Very happy based on the earlier discussion this morning that I added more at 202p earlier.
Yes agreed, not really acceptable for H & T (LON:HAT) to issue the trading update during market hours.
Maybe it was all a bit hurried in response to the share price falls of the last few days - they don't normally provide an update at this stage.
It is however an encouraging update and I have bought back in.
They do flag one trend that seems curious to me :
Not sue I can really understand why that might be the case. The only thing I can think is that maybe it is a temporary reversal of the longer term trend for people to spend on "experiences" rather than "things".
Any other ideas? And might there be a read across to other businesses?
re during-day timing on the H & T (LON:HAT) update, I do wonder if it may have been prompted or brought-forwards by the Ramsdens Holdings (LON:RFX) announcement and their subsequent price jump - which directors wouldn't want a piece of that demand?!
Fair point, perhaps H &T were just responding in kind to the Ramsdens announcement. I also note that a couple of posters on ADVFN say they had lobbied for a trading update in recent days. It is what it is, but still a bit of a black mark from my point of view.
Due to the timing I had also assumed the H & T (LON:HAT) announcement was mainly to match Ramsdens to confirm they too would be staying open as an essential business.
I'm no longer in HAT. I'd kept it prior to covid as a hedge against a bear market but it didn't work. It and Begbies Traynor (LON:BEG) had been thrown out along with the bathwater in March when everything went down. I bought back into both but sold out of HAT a couple of months back as it was just drifting along and their seemed to be greener pastures elsewhere.
re H & T (LON:HAT), I thought their retail sales were second hand items - people having more time to spend on getting something cheaply? Something that will continue?
Called up one of their branches today to confirm that they were open. During lockdown - Pawnbroking side is open. Retail side - i.e. jewelry stuff etc - not open. Pawnbroking side is their largest rev generator
H & T (LON:HAT) just issued an RNS, "ahead of market expectations", so very timely thoughts rmillaree!
i think a surge in the shareprice when i am pondering a purchase is very untimely :(
Made decision to buy at 208 after making a cross read of Ramsdens Holdings (LON:RFX) ! Very blessed.
Here are my heat maps for today.
Small cap 'interesting':
Small cap unfiltered (limited to top 80):
And also the big movers today (moving more than the 20d ATR against either yesterdays close, or todays open - not limited to small caps):
And here is the key:
Good luck, and stay safe.
Greensiax
Hi Paul any thoughts on Dwf?
Thoughts on Superdry (LON:SDRY) please. Is the range improvement as good as Dunkie suggests? He made some chunkypurchases recently - at above the current SP.
Superdry stores are a problem and imo were long before coronavirus. They are often in high profile towns and Cities and in expensive locations, and there is one thing the same in every one I’ve ever visited; there is usually no-one else in the store! So were some of those stores like in London and Edinburgh as well as top European Cities an expensive ego trip for Julian Dunkerton? I also think their stores are dark, noisy and claustrophobic, but maybe they appeal to young shoppers at times I’m not there? If not then their stores will continue to be a luxury Superdry can ill afford, and a drain on their business even when High Street shopping eventually returns to more normal.....or at least what’s left of our High Streets.
Does the brand look tired?
Tired Ken? I would say comatose! Used to have nice tank tops for the beach with Japanese writing on them back in the day, but nothing else distinctive. Doubt they even register on todays Boohoo (LON:BOO) buyer.
I've been 'fortunate' to receive Superdry (LON:SDRY) sweaters over the last 2 Christmases. I fear this year's offering :)
Superdrab indeed!
grumpy5,
I wouldn't get misled by Dunkerton's buying - chump change compared to what he's taken out.
2018-01-26
J.M. Dunkerton SELL 1,000,000 @ 1,780.00p 17,800,000 25.36
2016-02-11
J.M. Dunkerton SELL
4,000,000 @ 1,200.00p 48,000,000 27.20
If your money was as hard earned as mine I would not be risking it on this jumble sale - but always DYOR.
Bonitabeach
I'm ignoring all Director share purchases of Superdry (LON:SDRY) , especially by Julian Dunkerton. The reason being that they could be emotional, not rational. Same with other Director buys at SDRY - people sometimes feel under a lot of pressure (even from themself) to demonstrate their commitment, when part of a team, led by a dominant figure, and in the heat of the moment, in times of trouble, people sometimes do highly irrational things.
I've done it myself on a much smaller scale - signing documents, guarantees, and paying in money to distressed businesses even when you know in your rational brain, that you're pouring money down the drain. But the short term relief to the tension, and the adulation from everyone else, at meeting the payroll costs again, can be quite addictive.
I'm not saying this is what's happening at SDRY, but the psychology might be similar maybe?
In summary, if a business is loss-making, and burning cash, and the founder is desperately trying to turn it around, then their Director buys are probably meaningless. Or even a contrarian signal.
Regards, Paul.
Excellent finals from Frontier Ip (LON:FIPP) (I hold), reporting that the value of their portfolio is up by nearly half, with NAV up from 41p to 51p. These gains mainly came from The Vaccine Group, who are developing vaccines for COVID-19 and Ebola for use in animals and from Polsiv Solar, who is collaborating with Bosch and another multinational to incorporate its solar technology into batteries for devices like laptops and mobile phones. These valuation increases both came from further funding rounds this year. Although the value of Exscientia did fall over the period, this is still the jewel in the crown. The company announced this year that it is involved in the world's first AI-designed drug to enter human clinical trials in partnership with Sumitomo Dainippon Pharma and is also already collaborating with Bayer AG. It raised $60m in a series C funding round during the year and Frontier own a 2.4% stake. I value Frontier on 1.5x NAV, which gives a current price target of 77p. Given the further funding rounds for the companies aforementioned, this is arguably a conservative target.
Although not a small cap, a positive trading update from Hikma Pharmaceuticals (LON:HIK) as well (again I hold), who reported a strong 1H for their generics business with new launches made and further expected. They are seeking to launch a generic asthma drug of GSK's in early 2021 and have increased FY guidance from this area. Branded and injectables are also performing well and worth noting on the latter that the company has signed an agreement with Gilead to produce remdesivir to combat COVID. I value Hikma at 14x EV/EBITDA, which gives a price target of £29.40.
Hi. I would be interested to hear views on Frontier IP’s impressive results. I hold. The market seems less impressed or perhaps too distracted by other issues?
Ramsdens Holdings (LON:RFX)
H & T (LON:HAT)
Ramsdrns update today (we will remain open - seems good news) has piqued my interest market cap is now below £36 mill and it looks like they managed to come through lockdown without losing any cash.
If we say they easily churn out £6 mill profit under normal market conditions that seems to be a tempting price for what appears to be a reasonably solid outfit (£16 mill cash and unused credit facility of £10 mill.
I am tempted by some bottom fishing here.
I note £H&T seems to be at a similarly cheapish multiple - slightly larger business and perhaps the higher level of profits offered by that increased size could give them that edge ref downside protection? (higher sales = higher overheads too so that may not be the case?)
Anyone any thoughts on which of these two outfits they prefer at present would be appreciated.
Long term holder of H & T (LON:HAT) here.
I think both companies are trading at very attractive multiples today driven by concern about bad debt and the risk of lockdowns expanding.
Given how bad the market is in the loan business (See companies like £NSF and £OPM) we are likely to see a lot of consolidation in the market in the future and those left standing could benefit a lot.
I expect a bounce when the next results come out as I expect gold prices to partly offset bad debt provisions etc. I think it'll take a fair few years to get to a point where it was at the start of the year.
I agree - the non-standard (formerly sub-prime !!) loans market has undergone a lot of change in last few years. Regulation has tightened a lot and a lot of companies have withdrawn - even before COVID struck. Usually, these companies can re-price loans/risk so that impairments rise but so does demand and interest rates. However, this time it hit so fast plus govt action to grant repayment holidays means a lot more will go under - just at the very moment when it should be good to be in this market. So survivors will get a bigger market and better pricing AND bigger market share in a highly regulated market that is difficult to break into. Non standard lending is a really specialised market that the main high street banks will shun and which has proven difficult for FinnTech to crack as data is patchy and personal judgement of willingness/ability to repay
I still hold lots of Non-standard Finance (LON:NSF) (a close to worthless binary bet on recovery after equity injection or bust now) and some Morses Club (LON:MCL) but would otherwise go for H & T (LON:HAT) as the core pawn shop model has been historically very resilient. H&T are now clear market leaders having bought pawn loans books cheaply out of administration as well as opened/taken on new sites in recent years. It won't grow hugely and its diversification efforts have been knocked back but it almost certainly will recover over time.
My commiserations on £NSF.
I held it but got out at about a 40% loss, this year I've tried to be much more focused on getting out of companies heading in the wrong direction.
I have tried to bottom fish H & T (LON:HAT) 4 x now. Once in June at 330, then at 317 this Aug prior to TU, then at 250 (thinking that it was a 4-yr low). Then today at 208. 1st 3 times, very hard to "go against PI sentiment". Perhaps with pawnbroking as usual (no retail biz allowed said a H & T (LON:HAT) staff to me), they can really go stronger from here (albeit with new ceo but John will still be around for a little bit more I understand.
H & T was one of Graham Neary's biggest holdings, he was really bullish about the company if you check through the archives. I have brought some today, looks cheap! Directors brought a decent amount of stock in September at around 270p mark, which was their first purchase in a while.
I used to be a holder (bought ~14, sold ~17, made a profit bu not an exceptional one) and have not looked into the latest company acct / announcements
but
had a quick look at the chart.
Not a big believer in TA but after a lot of bitter experience do accept that momentum effects are real.
This chart is not trending up. Would advise more investigation before doing anything.
Others may be able to correct me.
H & T (LON:HAT) I hold. SP was trending downwards until 1. today's annoucement + 2. able to trade during lockdown (1st lockdown it could not) - I reckon today - these 2 are the catalyst. Potentially, with a Simon Thompson article , further acceleration.
RE: Ramsdens Holdings (LON:RFX) v H & T (LON:HAT)
Anyone any thoughts on which of these two outfits they prefer at present would be appreciated.
I don't have time to check but as I recall Ramsdens Holdings (LON:RFX) has a much larger contribution from its foreign exchange business which is essentially moribund at the moment.
On a broader, and depressing note, the Danes have discovered a CV19 mutation that appears to prevent antibody production and which would be resistant to any of the vaccines under production. They're about to slaughter 15 million mink which seem to be the transmission vector, but it's already been detected in people. 2020 is really not going to be a year to remember.
timarr
On a broader, and depressing note, the Danes have discovered a CV19 mutation that appears to prevent antibody production and which would be resistant to any of the vaccines under production. They're about to slaughter 15 million mink which seem to be the transmission vector, but it's already been detected in people. 2020 is really not going to be a year to remember.
Yes, I read about this earlier but it's not the first instance in Europe and mink have already been culled in the Netherlands and Spain. 2020 is almost history now, it's 2021 and beyond I'm more worried about... more lockdowns to come after this one I fear.
All the best, Si
Yes, this is correct - the F/X side is currently a risk factor for RFX (but on the other hand will likely accelerate and intensify the bounce when it eventually comes and in the meantime they have the solid pawn brokerage business to keep them ticking over). The other plus point for RFX is that they do not engage in HCSTC loans (the area the H&T is under regulator investigation for) so that's one risk factor that H&T has which RFX does not. Current gold price and pawn brokerage profits should help both of them tick along and help see them through any short term lockdown slowdown issues and then we should start to get a rise once lending activity comes back and (for RFX) travel starts to reopen. I hold both as long term slow and steady type bets (unfortunately sitting just under breakeven on RFX and fairly heavily underwater on H&T at the moment but will stick it out for the long term - wish I had the chance to buy in a position at current price instead!).
BIACS
I have both at the wrong price especially HAT last week was a disaster. RFX wins the compare companies function on Stoko
Morses Club (LON:MCL) is even more bombed out. It seems the whole sector is being weighed on by the expectation of bad debts. However could this be offset by demand for new loans given cash flow pressures of a stop start economy?
Having bought just before the most recent trade update, I think there were a few factors that have made the SP bomb out
1. Artemis dumping shares - the SP had a weird action, and the same action could be seen with H & T (LON:HAT) just before August update (Artemis disposed shares again)
2. Non release of provisional figures until later this month. Makes PIs suspicious.
3. The bit here in the recent TU was so badly worded - since if one is to read the RNS quick to get an overall feel given the limited time constraint prior to deciding whether to chuck the shares or buy - it could have been misconstrued as that the overall biz was to breakeven in 2022 (I know that it says "digital" but given the short time frame, I believe many PIs interpretated wrong) - The impact of Covid-19 on the overall business has impacted the trajectory of Morses Club's Digital business to profitability and, whilst performance compared to last year is very positive, the trajectory of cash and sales has been impacted by the fall in customer demand, as Morses Club's focus on the quality of its lending has led to much lower volumes of sales than our pre-Covid forecast anticipated. It is now expected that the digital business will reach a break-even position in Spring 2022. The fulfilment of significant re-engineering activity in our digital business is broadly complete, and the introduction of a new loan management platform which allows for the integration of linked banking and credit products is due to be launched in H2 FY21
On an encouraging note - bank debts were not that bad during most recent TUs for banks, so maybe Morses Club (LON:MCL) are not so either ..just maybe ...
H & T (LON:HAT) have now released an update for those who haven't seen it yet.
"The Group's balance sheet and liquidity remains strong with net cash of approximately £30m, no debt, an undrawn revolving credit facility of £35m and net assets of £134m."
and H & T (LON:HAT) release an RNS at 11!
Hi Paul
If you are looking for ideas for today, this line in Pci- Pal (LON:PCIP) AGM statement stood out to me:
"As a result of the strong start to the year in sales and customer deployments, first quarter revenues are 44% ahead of the comparative period last year".
A loss-making tiddler, but the trajectory looks interesting.
Jon
Pci- Pal (LON:PCIP) growth story makes exciting reading. Some commentators think costs will rise to match revenue growth - the co says it expects positive cash flow followed by profitability in ye June 2022. Take your pick!
I bought a starter stake in Pci- Pal (LON:PCIP) recently on two factors:
First, as you imply, historic development suggests breakeven is soon achievable - perhaps before forecasts indicate. Second, they are a cloud based service providing a similar (on-line credit card payment) service to Eckoh (LON:ECK), but without the need to deliver an on-site server. This makes smaller projects viable and may be a benefit for larger sites also. Eckoh (LON:ECK) have progressed well over the last couple of years and Pci- Pal (LON:PCIP) have the opportunity to do the same. From a current MCap of £24M it could grow rapidly from here if sales momentum is maintained.
HollandSmith & MrContrarian:- Unbelievable.
100% agree with Laughton re HS and MrC.
N Brown (LON:BWNG) interesting announcement. Good set of h/y results in the circumstances. Looks like they will make circa 14p adjusted EPS for the full year : taking into account the £100m placing that's more likely to be 9-10p though.
net debt come down to £411 but remember this is offset by customer loan balances of £540m (after £90m of bad debt provisions which should ultimately prove to be better as cash collections are remaining stable to date) so really this equates to £128m+ of real assets
Underwritten £100m placing at 57p means unsecured debt eliminated reducing loan book further and allowing for investment in new growth from a strong balance sheet base.
Interesting to see Home division increasing 24.5% too which could become a strong contributor assuming they get this right.
Hmm interesting - looks significantly undervalued to me. I am already long but will probably take up my rights or add the equivalent if I get them cheaper in the market
I to am a holder but can't understand why sales they are not flying? Other "good" fashion internet business in lockdown seem to be having record results eg BOO & Asos.
IMO I think SDRY/ASOS has structural issues.
The structural issue is that they are a 'mum/dad' brand - bought by parents. Children do not want to buy the same stuff as their parents.
BOO is avoiding this by starting up PLT etc. In 5 - 10 years time I would not be surprised if PLT has more turnover than BOO and the BOO mgt will be working on the next iteration.
Good morning, anyone else like the numbers for Paypoint (LON:PAY) but not the general direction of price?
The potential fine of up to 10% of revenue by Ofgem is scaring of investors!
Interesting announcement this morning from £BKS where they have launched an Analytics as a service application to assist both customers and non customers (from a cloud perspective.) Very little information on this one in terms of potential but I am guessing they will try and use this to get more Tier one customers onboard as well as cross selling to existing customers. I am long on this and still thinks it could be a potential multibagger long term but growth is still steady rather than spectacular and the build out of infrastructure continues to be a stop on profit. The price is and always has been a bit rich but clearly not one for the traders out there.
My morning smallcap tweet:
Telecom Egypt Co SAE (LON:TEEG) N Brown (LON:BWNG) Fireangel Safety Technology (LON:FA.) Open Orphan (LON:ORPH) Wameja (LON:WJA) Joules (LON:JOUL) Rank (LON:RNK) Concurrent Technologies (LON:CNC) Zoetic International (LON:ZOE) Superdry (LON:SDRY) DFS Furniture (LON:DFS) DWF (LON:DWF) Ramsdens Holdings (LON:RFX) Works co uk (LON:WRKS) Hansard Global (LON:HSD) £D4T4, Zotefoams (LON:ZTF)
Telecom Egypt (TEEG) buys extra 20Mhz spectrum for 10 years for $305m to grow capacity. [SP=NA Cap=NA]
Brown N (BWNG) £100m placing and OO at 57p, a 3% discount, mostly to repay some debt. This co looked like a bust a few months ago. Will move to AIM. [SP=37.25 Cap=106m]
FireAngel Safety Technology (FA.) Oct rev down only 4%. However the Scottish Government has proposed a 1 year extension for compliance to alarm installation. No FY guidance. [SP=13.2 Cap=17m]
Open Orphan (ORPH) wins £2.5m contract for a flu human challenge study with a US biotech. [SP=25 Cap=166m]
Wameja (WJA) Takeover delayed to 5 Feb (guided). "Seamless has notified Wameja of the potential for further claims under the indemnity in the SPA regarding third party intellectual property utilised in eServGlobal's "Paymobile" platform." Mastercard will seek to resolve the Potential Indemnity Claims directly with Seamless. [SP=7.26 Cap=167m]
Joules (JOUL) encouraging trends reported on 23 Sept have continued, with sales still ahead of mgmt expectations. Guides FY in line despite lockdown. [SP=91.14 Cap=105m]
Rank (RNK) confirms rumour of placing of up to 20% of shares in issue. [SP=86.3 Cap=337m]
Concurrent Technologies (CNC) launches new high performance AdvancedMC processor board aimed at wireless applications such as 4G/5G test instruments. [SP=79.63 Cap=58m]
Zoetic (ZOE) revised sale of DTU and Kansas Nitrogen Assets. Path not buying Nitrogen Assets, won't pay a royalty on future revenues from DTU. Also no orderly market agreement for sale of Path shares. [SP=44.5 Cap=87m]
Superdry (SDRY) Q2(Oct) rev down 22.8%, 1.3% better than Q1. Margin squeezed. [SP=151.1 Cap=124m]
DFS Furniture (DFS) lockdown measures not expected to materially impact H1(Dec) profitability due to very strong order bank levels, and the delivery lead times. "Furthermore, our experience of the prior lockdown periods was that substantially all order intake disrupted during the lockdown period was either deferred until showrooms reopened or was captured online." [SP=203 Cap=518m]. I'm short.
DWF (DWF) guides H1(Oct) u/l adj pretax £13m cf FY20 £14m. FCF over £10m. [SP=60.52 Cap=196m]
Ramsdens (RFX) stores will remain open in lockdown. [SP=111.5 Cap=34m]. I hold.
TheWorks.co.uk (WRKS) guides H1(Oct) LFL up 10.6%, significantly ahead of the Board's expectations. Stores closed in lockdown. No FY guidance. [SP=25.8 Cap=16m]
Hansard Global (HSD) Q1(Sep) new business (Present Value) down 4.5%, "in-line with our general experience to-date of the Covid-19 environment." [SP=33 Cap=45m]
D4T4 Solutions (D4T4) contract wins will add c.£5.5m to FY rev. Remains confident about prospects. [SP=156 Cap=63m]
In line: Zotefoams (LON:ZTF)
// AZN: Year-to-date and Q3 2020 results
// Total Revenue increased by 7% in the year to date (10% at CER) to $3,450m.
// Half-year Report
//Revenue declined 11.7% on an organic constant currency basis during the first half of FY21
// Trading Statement
// We are reiterating our guidance for global Injectables core revenue of between $950 million and $980 million for 2020, with core operating margin in the range of 38% to 40%.
// Half-year Report
// We have made good progress with our Financial Services transformation plan and streamlined our product offering. We still expect to double profit and returns in our Financial Services business within 5 years, despite the challenges of the current environment.
// Half Year Results
// The demand for cars has been strong since early June, with consumer demand on Auto Trader consistently being 20% or more above prior year levels. We believe car retailers will be allowed to operate both home delivery and click & collect services and we expect consumer activity that we have seen through October and into November will sustain some sales.
// Q3 2020 Trading Update
// Group net written premiums of £4,663m were down 3%
// Q3 2020 Business Update
// We continue to focus on maintaining and extending income and in the second half have taken lease renewal income up to c.£16m from the c.£8m reported on 13 October. Overall these transactions were 6% above the previous rent and 11% below June 2020
// Half-year Report
// The load factor decreased from 94.6% to 64.3%.Passenger ticket revenue decreased by 78.9% to €201.8 million
// Half-year Report
// Revenue declined -4%
// Q3 Trading Update
// Revenues declined -10%
// Q3 Trading Statement
// Gross premiums written increased by 14% year on year to $658.7 million
// Results for the six months ended 31 August 2020
// Revenue declined -81%
// Q3 2020 Trading Update
// Group revenue is recovering and decreased by 5.1% year over year compared to an H1 2020 revenue decrease of 30.7%.
// COVID-19 Update
// Manufacturing and deliveries continuing through current national lockdowns. Robust balance sheet; net cash position with access to over £300m of funds. Current lockdown measures not expected to materially impact profitability for the first half
// Acquisition
// Card payments in the UK continue to grow and have been the preferred payment method since 2016, with significant increases in usage seen over the Covid-19 pandemic. However, there remains substantial growth potential, with circa 2 million SMEs still not accepting card payments.
// Half Year Results
// Underlying EPS decreased by 27.5% to 12.9p per share (2019: 17.8p per share) reflecting the reduction in profits.
// HY21 Interim Trading Statement
// The Group has continued to enjoy improved activity levels since Q4 of FY20, which was impacted negatively by COVID-19. Revenue growth for the year to date is more than 14%, as activity levels increase towards pre-COVID levels.
// COVID-19 Operational Update
// confirms that its operations will remain open for the duration of the lockdown period in England which came into effect today following the passing of legislation by UK Parliament, and which ceases on 2 December 2020.The Company intends to continue operating from all its sites, providing a nation-wide delivery service, collection service from its trade counter network, and ongoing customer support while prioritising the safety and protection of its people, customers and necessary visitors to site.
// Operational and Trading Update
// Revenue grow 22%
// New £2.5m Influenza Challenge Study Contract Win
// Open Orphan plc (ORPH), a rapidly growing specialist CRO pharmaceutical services company which is the world leader in the testing of vaccines and antivirals using human challenge clinical trials is pleased to announce the signing of a £2.5 million contract by hVIVO
// Trading Statement
// Revenue declined - 23.3%
// Business and Trading Update
// The encouraging trends reported in the Group's trading update on 23 September 2020 have continued, with sales for the Period remaining ahead of the Board's expectations. This has been driven by strong year-on-year e-commerce growth of 35%, with e-commerce revenue accounting for 70% of the Group's retail sales in the Period. The Group's stores performed ahead of the Board's expectations during the Period, with sales since the re-opening of Joules stores in July down by 18% year-on-year.
// New contract wins
// These wins evidence the strength of the pipeline of business opportunities with new and existing clients alike that is underpinning the Board's confidence in delivering a strong second half of the year.
// Launch of high performance Advanced MC Board
// announces the launch of a new high performance AdvancedMC processor board
// COVID-19 Update
// Everyman Media Group plc announces that, following the new Government guidelines which came into effect this morning, its venues will be closed from today until further notice.
// Half-year Report
// As of 31 August 2020, our US micro-cap portfolio consisted of 22 businesses, which includes four 'verticals' and 14 co-investments, across seven industries; this portfolio was valued at 8.5x EBITDA, after applying an average 18% marketability discount to public comparables.
// Trading update for quarter ended 30 September 2020
// In Present Value of New Business Premiums ("PVNBP") terms, levels of new business in Q1 2021 were 4.5% lower than Q1 2020
// Final Results
// announce its audited financial results for the year ended 31 December 2019.
// COVID-19 Update
// announces that, following the new Government guidelines which came into effect this morning, its venues will be closed from today until further notice.
// Kin and Carta (LON:KCT) - Revenue declined -7%
// Biffa (LON:BIFF) - Revenue grow +18.1%